drugset / Trial / NCT01437865

Gadofosveset for Axillary Staging in Breast Cancer Patients

NCT01437865

Completed 10 enrolled Maastricht University Medical Center
NaSingle-groupOpen-labelDiagnostic

Summary

The aim of this pilot-study is to examine the accuracy of gadofosveset enhanced MRI compared to current nodal staging methods. The accuracy of MRL will be determined on the basis of a node-to-node matching of imaged nodes to the definitive histopathology. The pathologic examination of the SNLB or ALND will be regarded as the golden standard for nodal involvement.

Timeline

Start
2011-09
Primary completion
2012-02
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadofosveset Diagnostic / imaging agent 0.03 mmol Intravenous

Indications